Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 5, 2012-04 ,pp. : 736-745

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targeting of TRPV1 by Resiniferatoxin, from Preclinical Studies to Clinical Trials

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 17, 2011-09 ,pp. : 2159-2170

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles

By Matsumura Yasuhiro  

Journal of Drug Targeting, Vol. 15, Iss. 7-8, 2007-08 ,pp. : 507-517

Informa Healthcare

Access to resources Recommend Favorite

Is pomegranate juice a potential perpetrator of clinical drug–drug interactions? Review of the in vitro, preclinical and clinical evidence

By Srinivas Nuggehally  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 38, Iss. 4, 2013-12 ,pp. : 223-229

Springer Publishing Company

Access to resources Recommend Favorite

Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond

By Barton Hugh A   Lai Yurong   Goosen Theunis C   Jones Hannah M   El-Kattan Ayman F   Gosset James R   Lin Jian   Varma Manthena V  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 459-472

Informa Healthcare

Access to resources Recommend Favorite